Skip to content

Clinical trials

Phase 1 Parkinson Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Country / region: China Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20151
20172
20182
20191
20202
20214
20221
20235
20242
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Not yet recruiting8
Recruiting6
Unknown status6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Luye Pharma Group Ltd.3
Shanghai East Hospital3
H. Lundbeck A/S2
Ruijin Hospital2
Second Affiliated Hospital, Zhejiang University, School of Medicine2
Xuanwu Hospital, Beijing2
Yiling Pharmaceutical Inc.2
iCamuno Biotherapeutics Ltd.2
Beijing Pins Medical Co., Ltd1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease35
Multiple System Atrophy2
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1
Central Nervous System Diseases1
Lewy Body Disease1
Movement Disorders1
Neurodegenerative Diseases1
Parkinsonian Disorders1
Urinary Bladder, Overactive1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.